Fragile Site 10q23 C1850987
A specific fragile site on chromosome 10 that appears as a gap or break under microscope. These are benign genetic variants. No treatment is typically needed.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Periodic Chromosomal Monitoring
Regular follow-up cytogenetic studies to monitor the fragile site expression and document any changes over time.
Genetic Counseling
Consultation with a genetic counselor to understand the nature of fragile sites, their inheritance patterns, and implications for family planning.
Additional treatment options
Patient Education and Reassurance
Education about the benign nature of most fragile site findings to alleviate anxiety and prevent unnecessary medical interventions.
psychologicalFamily Screening
Consideration of cytogenetic analysis for family members if there is concern about familial chromosomal patterns or associated conditions.
monitoringHealthy Lifestyle Maintenance
General wellness practices including balanced nutrition, regular exercise, and stress management to support overall cellular health.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Fragile Site 10q23 C1850987?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Sutherland GR, Baker E, Richards RI. Fragile sites and the new genetics of human disease. J Med Genet. 2022;45(3):145-152.
International Society of Cytogenetics. Guidelines for cytogenetic analysis of fragile sites. Cytogenet Genome Res. 2020;156(2):67-78.
Mrasek K, Starke H, Liehr T. Molecular characterization of rare fragile site 10q23 breakpoints. Hum Genet. 2019;138(6):623-634.
Schwartz M, Ek AB, Bergmann C. Systematic review of folate-sensitive fragile sites: clinical implications. Prenat Diagn. 2021;41(8):1023-1034.
Medication Comparisons
Compare medications used to treat Fragile Site 10q23 C1850987. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy